Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 677 (LINC00677) is a member of the lincRNA family, which are RNA transcripts longer than 200 nucleotides that do not encode proteins and do not overlap with protein-coding genes. LincRNAs regulate gene expression via chromatin remodeling, transcriptional control, and epigenetic modification, either acting locally (cis) or distantly (trans), though the specific functions of LINC00677 remain incompletely characterized. Some lincRNAs are involved in disease pathogenesis, such as cancer, but direct disease associations or biomarker status for LINC00677 have not been revealed in key genomic or molecular databases. The gene is associated with the alias C14orf74 and is classified as a non-coding transcript that may modulate biological processes related to gene expression, cell cycle, and chromatin state, but it is not considered a conventional therapeutic target.
Not applicable. There are no drugs known to act on LINC00677, so mechanisms of action are not described in drug literature
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 677 (LINC00677).